ATE273715T1 - Alkyldextran-polyalcohol arzneimittel-komplexe - Google Patents

Alkyldextran-polyalcohol arzneimittel-komplexe

Info

Publication number
ATE273715T1
ATE273715T1 AT97924325T AT97924325T ATE273715T1 AT E273715 T1 ATE273715 T1 AT E273715T1 AT 97924325 T AT97924325 T AT 97924325T AT 97924325 T AT97924325 T AT 97924325T AT E273715 T1 ATE273715 T1 AT E273715T1
Authority
AT
Austria
Prior art keywords
alkyldextrane
polyalcohol
medicinal
complexes
spacer
Prior art date
Application number
AT97924325T
Other languages
English (en)
Inventor
Kazuhiro Inoue
Hiroshi Susaki
Masahiro Ikeda
Hiroshi Kuga
Eiji Kumazawa
Akiko Togo
Original Assignee
Daiichi Seiyaku Co
Drug Delivery System Inst Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co, Drug Delivery System Inst Ltd filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE273715T1 publication Critical patent/ATE273715T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT97924325T 1996-06-06 1997-06-05 Alkyldextran-polyalcohol arzneimittel-komplexe ATE273715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14442196 1996-06-06
PCT/JP1997/001914 WO1997046260A1 (en) 1996-06-06 1997-06-05 Drug complexes

Publications (1)

Publication Number Publication Date
ATE273715T1 true ATE273715T1 (de) 2004-09-15

Family

ID=15361795

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924325T ATE273715T1 (de) 1996-06-06 1997-06-05 Alkyldextran-polyalcohol arzneimittel-komplexe

Country Status (17)

Country Link
US (2) US6436912B1 (de)
EP (1) EP0916348B1 (de)
JP (1) JP4137183B2 (de)
KR (1) KR20000016558A (de)
CN (1) CN1227499A (de)
AT (1) ATE273715T1 (de)
AU (1) AU723392B2 (de)
CA (1) CA2257245A1 (de)
DE (1) DE69730332T2 (de)
DK (1) DK0916348T3 (de)
EA (1) EA001550B1 (de)
ES (1) ES2229354T3 (de)
ID (1) ID18298A (de)
NO (1) NO985666L (de)
PT (1) PT916348E (de)
TW (1) TW527183B (de)
WO (1) WO1997046260A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH071238U (ja) * 1993-06-11 1995-01-10 株式会社大井製作所 ドアロック操作用のロッド連結装置
TW409058B (en) 1996-06-06 2000-10-21 Daiichi Seiyaku Co Method for preparation of a drug complex
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex
CN1250293C (zh) * 1998-05-22 2006-04-12 第一制药株式会社 药物复合物
IL142842A0 (en) * 1998-10-30 2002-03-10 Daiichi Seiyaku Co Dds compounds and method for assaying the same
US6677456B2 (en) 1999-10-15 2004-01-13 Daiichi Pharmaceutical Co., Ltd. Pentacyclic taxan compound
AU774787B2 (en) * 1999-10-15 2004-07-08 Daiichi Sankyo Company, Limited Pentacyclic taxane compounds
MXPA02012791A (es) * 2000-06-29 2003-12-11 Daiichi Seiyaku Co Compuestos dds y metodo para prepararlo.
CA2415922A1 (en) * 2000-07-13 2002-01-24 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical compositions containing dds compound
US20030092608A1 (en) * 2001-08-21 2003-05-15 Takayuki Kawaguchi Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
TWI313609B (en) * 2001-08-21 2009-08-21 Mitsubishi Tanabe Pharma Corp Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
US7585491B2 (en) * 2002-12-13 2009-09-08 Immunomedics, Inc. Immunoconjugates with an intracellularly-cleavable linkage
TW200306314A (en) * 2002-04-16 2003-11-16 Tanabe Seiyaku Co Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
KR101520209B1 (ko) * 2003-11-06 2015-05-13 시애틀 지네틱스, 인크. 리간드에 접합될 수 있는 모노메틸발린 화합물
EP1854807A4 (de) * 2005-02-18 2009-04-01 Univ Tokushima Eine polyoxyalkylenkette enthaltendes lipidderivat und eine lipidfilmstruktur, die ein solches derivat enthält
CN100516067C (zh) * 2006-01-10 2009-07-22 上海恒瑞医药有限公司 具有抗肿瘤活性的紫杉酚衍生物
EP3858385A3 (de) 2010-05-25 2021-10-27 Syndevrx, Inc. Polymer-konjugierte metap2-hemmer und therapeutische verfahren zu ihrer verwendung
US9895449B2 (en) 2010-05-25 2018-02-20 Syndevrx, Inc. Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
HUE039000T2 (hu) 2012-10-11 2018-12-28 Daiichi Sankyo Co Ltd Antitest-gyógyszer konjugát
EP2910573B1 (de) 2012-10-19 2020-02-19 Daiichi Sankyo Company, Limited Durch bindung über einen linker mit hydrophiler struktur hergestelltes antikörper-wirkstoff-konjugat
BR112015025892A2 (pt) 2013-04-10 2017-07-25 Syndevrx Inc inibidores de metap2 e métodos para tratar obesidade
WO2015071841A1 (en) 2013-11-12 2015-05-21 Druggability Technologies Holdings Limited Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
CA2933666C (en) 2013-12-25 2021-08-03 Sapporo Medical University Anti-trop2 antibody-drug conjugate
DK3466976T3 (da) 2014-01-31 2021-12-13 Daiichi Sankyo Co Ltd Anti-her2-antistof-lægemiddelkonjugat
KR102624244B1 (ko) 2014-04-10 2024-01-11 다이이찌 산쿄 가부시키가이샤 항her3 항체-약물 콘주게이트
US11185594B2 (en) * 2014-04-10 2021-11-30 Daiichi Sankyo Company, Limited (Anti-HER2 antibody)-drug conjugate
IL290959B2 (en) 2015-06-29 2023-04-01 Daiichi Sankyo Co Ltd Preparations containing antibody-drug conjugates and methods for their production
JP2019501898A (ja) 2015-12-10 2019-01-24 シンデブルックス,インコーポレイティド フマギロール誘導体およびその多形体
WO2017123603A1 (en) 2016-01-11 2017-07-20 Syndevrx, Inc. Treatment for tumors driven by metabolic dysfunction
CA3036941C (en) 2016-10-07 2023-02-21 Daiichi Sankyo Company, Limited Therapy for drug-resistant cancer by administration of anti-her2 antibody/drug conjugate
US11273155B2 (en) 2016-12-12 2022-03-15 Daiichi Sankyo Company, Limited Combination of antibody-drug conjugate and immune checkpoint inhibitor
WO2018135501A1 (ja) 2017-01-17 2018-07-26 第一三共株式会社 抗gpr20抗体及び抗gpr20抗体-薬物コンジュゲート
TW202330036A (zh) 2017-05-15 2023-08-01 日商第一三共股份有限公司 抗體-藥物結合物之製造方法
CA3073924C (en) 2017-08-31 2023-10-17 Daiichi Sankyo Company, Limited Improved method for producing antibody-drug conjugate
KR102630307B1 (ko) 2017-08-31 2024-01-29 다이이찌 산쿄 가부시키가이샤 항체-약물 콘주게이트의 신규 제조 방법
CA3100608A1 (en) 2018-05-18 2019-11-21 Daiichi Sankyo Co., Ltd. Anti-muc1 antibody-drug conjugate
JP2022512826A (ja) 2018-10-26 2022-02-07 シンデブルックス,インコーポレイティド MetAP2阻害剤のバイオマーカーとその応用
MX2022000449A (es) 2019-07-10 2022-04-25 Cybrexa 2 Inc Conjugados peptídicos de citotoxinas como terapéuticos.
EP3996749A1 (de) 2019-07-10 2022-05-18 Cybrexa 3, Inc. Peptidkonjugate von auf mikrotubuli abzielenden mitteln als therapeutische wirkstoffe
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59220197A (ja) * 1983-05-30 1984-12-11 Snow Brand Milk Prod Co Ltd 新規な含窒素多糖体およびその製造方法
JP2604930B2 (ja) 1990-12-14 1997-04-30 株式会社ディ・ディ・エス研究所 ヒアルロン酸およびコンドロイチン誘導体
DE69225542T2 (de) 1991-02-21 1998-09-10 Drug Delivery System Inst Ltd Carboxymethylmannoglukan und derivate davon
JP3359955B2 (ja) 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
WO1994019376A1 (en) 1993-02-26 1994-09-01 Drug Delivery System Institute, Ltd. Polysaccharide derivative and drug carrier
JPH0784481A (ja) 1993-06-26 1995-03-31 Ricoh Co Ltd 画像形成装置
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
SG50747A1 (en) 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
TW409058B (en) 1996-06-06 2000-10-21 Daiichi Seiyaku Co Method for preparation of a drug complex
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex
CN1250293C (zh) 1998-05-22 2006-04-12 第一制药株式会社 药物复合物
IL142842A0 (en) 1998-10-30 2002-03-10 Daiichi Seiyaku Co Dds compounds and method for assaying the same

Also Published As

Publication number Publication date
AU2978797A (en) 1998-01-05
EA001550B1 (ru) 2001-04-23
EA199900004A1 (ru) 1999-06-24
US6436912B1 (en) 2002-08-20
TW527183B (en) 2003-04-11
EP0916348B1 (de) 2004-08-18
EP0916348A4 (de) 2000-11-29
KR20000016558A (ko) 2000-03-25
CA2257245A1 (en) 1997-12-11
NO985666D0 (no) 1998-12-04
AU723392B2 (en) 2000-08-24
ID18298A (id) 1998-03-26
ES2229354T3 (es) 2005-04-16
EP0916348A1 (de) 1999-05-19
US6838450B2 (en) 2005-01-04
DE69730332T2 (de) 2005-09-22
CN1227499A (zh) 1999-09-01
PT916348E (pt) 2004-10-29
US20030171262A1 (en) 2003-09-11
DK0916348T3 (da) 2004-12-06
DE69730332D1 (de) 2004-09-23
JP4137183B2 (ja) 2008-08-20
NO985666L (no) 1999-02-04
WO1997046260A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
ATE273715T1 (de) Alkyldextran-polyalcohol arzneimittel-komplexe
NO301829B1 (no) 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse
EP0787009A4 (de) Krebs hemmende peptide
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
AU6701890A (en) Process for the production of biologically active protein
ATE386808T1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
ZA91353B (en) Pharmaceutical and cosmetic compositions
CA2144312A1 (en) Unsaturated aliphatic dicarboxylic acids
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
DE69124705D1 (de) Hexapeptide als liganden des anaphylatoxin-rezeptors
HK1001004A1 (en) Bpc peptides their preparation and use
AU1064988A (en) Polymer complexes of metals useful as pharmaceutical agents
CA2163197A1 (en) Tri(platinum) complexes
DE69837824D1 (de) Löslicher Natamycin-Proteinkomplex
HU912010D0 (en) Utilization of macroring amino-phosphonic acid complexes as transformation agents
IT8868117A0 (it) Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
ATE186734T1 (de) L-lysyl-glycyl-l-histidin und entsprechende pharmazeutische zusammensetzungen zur wundheilung
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
EA199900998A1 (ru) Полутвердый фармацевтический препарат, содержащий декскетопрофентрометамол
FI933507A (fi) Bisyklopolyatsamakrosyklofosfonihappoja, niiden komplekseja ja konjugaatteja käytettäväksi varjoaineina ja menetelmä niiden valmistamiseksi
DE59107762D1 (de) Komplexe, enthaltend S(+)-Phenyl-alkansäuren und alpha-Hydroxy-alkansäuren
FI933506A (fi) Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaatteja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
CA2176603A1 (en) Novel palladium complexes and methods for using same in the treatment of tumors and psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0916348

Country of ref document: EP

REN Ceased due to non-payment of the annual fee